GSK to Pay $2.2bn in Settlements Over Zantac Cancer Allegations
British pharmaceutical giant GSK has agreed to pay up to $2.2 billion to resolve thousands of lawsuits in the U.S. related to claims that a discontinued version of its popular heartburn medication, Zantac, caused cancer. The company has reached settlement agreements with 10 law firms representing approximately 80,000 claimants, covering 93% of the cases filed….